Literature DB >> 3793659

Molecular basis of resistance of influenza A viruses to amantadine.

A J Hay, M C Zambon, A J Wolstenholme, J J Skehel, M H Smith.   

Abstract

Amantadine (1-aminoadamantane hydrochloride) is effective in the prophylaxis and treatment of influenza A infection. In tissue culture this selective, strain-specific antiviral inhibits either the initiation of infection or virus assembly. The basis of these actions is similar and both the haemagglutinin and M2 proteins are implicated suggesting that amantadine interferes with their functions or the interactions between these two virus proteins. Mutations which confer resistance to amantadine are restricted to four amino acids within a hydrophobic sequence of M2 indicating that the primary target of drug action is the membrane-associated portion of this molecule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3793659     DOI: 10.1093/jac/18.supplement_b.19

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  53 in total

1.  Coexistence of two adamantane binding sites in the influenza A M2 ion channel.

Authors:  Matthew R Rosenberg; Marco G Casarotto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

2.  Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus.

Authors:  Ekta Khurana; Matteo Dal Peraro; Russell DeVane; Satyavani Vemparala; William F DeGrado; Michael L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-14       Impact factor: 11.205

Review 3.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  Distribution and dynamics of adamantanes in a lipid bilayer.

Authors:  Chee Foong Chew; Andrew Guy; Philip C Biggin
Journal:  Biophys J       Date:  2008-10-03       Impact factor: 4.033

5.  Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.

Authors:  Mozibur Rahman; Sheikh Ariful Hoque; Mohammad Ariful Islam; Sabita Rezwana Rahman
Journal:  Virus Genes       Date:  2017-04-11       Impact factor: 2.332

6.  Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein.

Authors:  S L Zebedee; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

7.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

8.  OpenFluDB, a database for human and animal influenza virus.

Authors:  Robin Liechti; Anne Gleizes; Dmitry Kuznetsov; Lydie Bougueleret; Philippe Le Mercier; Amos Bairoch; Ioannis Xenarios
Journal:  Database (Oxford)       Date:  2010-07-06       Impact factor: 3.451

9.  Detection of adamantane-resistant influenza on a microarray.

Authors:  Michael B Townsend; James A Smagala; Erica D Dawson; Varough Deyde; Larisa Gubareva; Alexander I Klimov; Robert D Kuchta; Kathy L Rowlen
Journal:  J Clin Virol       Date:  2008-03-04       Impact factor: 3.168

10.  Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding.

Authors:  David J Allen; Rob Noad; Dhan Samuel; Jim J Gray; Polly Roy; Miren Iturriza-Gómara
Journal:  Virol J       Date:  2009-09-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.